Walleye Trading
LFCR icon

Walleye Trading’s Lifecore Biomedical LFCR Stock Holding History

Walleye Trading’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,000
Closed -$12 – 4743
2017
Q1 		$12 Sell
1,000
-1,200
-55% -$15.2K ﹤0.01% 4286
2016
Q4 		$30K Buy
+2,200
New +$30.5K ﹤0.01% 3910
2015
Q4 		– Sell
-1,000
Closed -$12K – 5487
2015
Q3 		$12K Buy
+1,000
New +$13.2K ﹤0.01% 4318

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Walleye Trading's LFCR Position: Q2 2017 in Review

Walleye Trading sold out of Lifecore Biomedical (LFCR) in Q2 2017, closing a stake of 1,000 shares — an estimated $12 sold.

Walleye Trading first reported a position in LFCR in Q3 2015 and held it in 3 quarters. The position peaked at $30K in Q4 2016. 94 funds tracked by Wall St. Rank hold LFCR as of Q2 2017.

  • Walleye Trading reported no remaining Lifecore Biomedical position as of Q2 2017 after selling out during the quarter.
  • Walleye Trading sold 1,000 Lifecore Biomedical shares in Q2 2017, an estimated $12.
  • Walleye Trading first reported a position in Lifecore Biomedical in Q3 2015 and held it in 3 quarters.
  • Walleye Trading's Lifecore Biomedical position peaked at $30K in Q4 2016.
  • 94 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2017.

Based on Walleye Trading's 13F filing for Q2 2017, filed 14 Aug 2017.